Lynch-like syndrome (LLS) tumors are considered mimics of LS tumors, also demonstrating MSI, loss of MMR protein expression, and absence of MLH1 methylation (Carethers 2014; Hampel et al. 2006). The gene discussed is MRC1; the disease is Leigh syndrome.